Frontlight ResearchEarly access
Trial site
Ustredni Vojenska Nemocnice Vojenska Fakultni Nemocnice Praha
- 8running trials
- 6closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Melanoma3 trials
- Heart failure2 trials
- Macular degeneration2 trials
- Stroke2 trials
- Type 2 diabetes2 trials
- Atrial fibrillation1 trial
- Coronary artery disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- High blood pressure1 trial
- Liver cirrhosis1 trial
- Obesity1 trial
- Phase
- Phase 311 trials
- Phase 22 trials
- Phase 41 trial
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Aura Biosciences2 trials
- Hoffmann-La Roche2 trials
- AbbVie1 trial
- AstraZeneca1 trial
- and 5 more
Running trials
Enrolling by invitation
Recruiting
Recruiting
Recruiting
A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD
Recruiting
Enrolling by invitation
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Macular degeneration2 recruiting
- Type 2 diabetes2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- Melanoma1 recruiting
- Obesity1 recruiting
Closed trials
Completed
Completed
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Active, not recruiting
Completed
Terminated
Zibotentan and Dapagliflozin Combination, EvAluated in Liver Cirrhosis (ZEAL Study)
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026